Italia markets open in 8 hours 37 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
54,64-1,89 (-3,34%)
Alla chiusura: 04:00PM EST
54,77 +0,13 (+0,24%)
Dopo ore: 06:21PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente56,53
Aperto55,84
Denaro54,64 x 4000
Lettera54,75 x 1400
Min-Max giorno54,60 - 56,30
Intervallo di 52 settimane54,60 - 69,75
Volume20.557.409
Media Volume11.315.338
Capitalizzazione121,281B
Beta (5 anni mensile)0,59
Rapporto PE (ttm)N/D
EPS (ttm)-2,42
Prossima data utili04 feb 2022
Rendimento e dividendo (forward)1,96 (3,47%)
Data ex dividendo30 set 2021
Stima target 1A73,12
  • GlobeNewswire

    INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of BMY, CTXS, OWLT, PTON Investors, Lead Plaintiff Deadlines Set

    NEW ORLEANS, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion

  • GlobeNewswire

    SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, CTXS, STNE INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion Deadline: December 6, 2021MISLEADING PROSPECTUS To le

  • GlobeNewswire

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMY, HEPS, PTON and Z

    CEDARHURST, N.Y., Nov. 23, 2021 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies. Bristol-Myers Squibb Company (BMY)Class: Investors who received Contingent Value Rights (“CVRs”) (BMY.RT) in exchange for their shares of Celgene Corporation (CELG) pursuant to Bristol-Myers’ acquisition of Celgene on November 20, 2019Lead Plaintiff Motion Deadline: December 6, 2021MISLEADING PROSPECTUS To learn